1. Evaluation of association between oral and topical terbinafine use in pregnancy and risk of major malformations and spontaneous abortion;Andersson;JAMA Dermatol,2020
2. Joint Formulary Committee . British National formulary. Edition 80. London: BMJ Group and Pharmaceutical Press, 2020.
3. Lamisil Tablets 250mg. Summary of Product Characteristics, UK. Novartis Pharmaceuticals UK Limited, 2020.
4. Lamisil 1% w/w Cream. Summary of Product Characteristics, UK. GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, 2016.
5. Sarker MS , RowLand K , Koren G . Pregnancy outcome following gestational exposure to terbinafine: a prospective comparative study [online]. Available: https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdrb.10026 [Accessed 6 October 2020].